225 related articles for article (PubMed ID: 22445882)
1. Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.
Oleson EB; Ferris MJ; España RA; Harp J; Jones SR
Eur J Pharmacol; 2012 May; 683(1-3):161-5. PubMed ID: 22445882
[TBL] [Abstract][Full Text] [Related]
2. Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties.
Lapa GB; Mathews TA; Harp J; Budygin EA; Jones SR
Eur J Pharmacol; 2005 Jan; 506(3):237-40. PubMed ID: 15627433
[TBL] [Abstract][Full Text] [Related]
3. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
[TBL] [Abstract][Full Text] [Related]
5. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization.
Velázquez-Sánchez C; Ferragud A; Murga J; Cardá M; Canales JJ
Eur Neuropsychopharmacol; 2010 Jul; 20(7):501-8. PubMed ID: 20413276
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
[TBL] [Abstract][Full Text] [Related]
7. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
O'Neill B; Tilley MR; Han DD; Thirtamara-Rajamani K; Hill ER; Bishop GA; Zhou FM; During MJ; Gu HH
Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
9. Cocaine-like neurochemical effects of antihistaminic medications.
Tanda G; Kopajtic TA; Katz JL
J Neurochem; 2008 Jul; 106(1):147-57. PubMed ID: 18363822
[TBL] [Abstract][Full Text] [Related]
10. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.
Ferragud A; Velázquez-Sánchez C; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
Psychopharmacology (Berl); 2009 Dec; 207(2):281-9. PubMed ID: 19756525
[TBL] [Abstract][Full Text] [Related]
11. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
Tanda G; Ebbs AL; Kopajtic TA; Elias LM; Campbell BL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2007 Apr; 321(1):334-44. PubMed ID: 17255465
[TBL] [Abstract][Full Text] [Related]
12. Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.
Jiang SZ; Sweat S; Dahlke SP; Loane K; Drossel G; Xu W; Tejeda HA; Gerfen CR; Eiden LE
J Neurosci; 2021 Jan; 41(4):711-725. PubMed ID: 33268547
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine.
Ferguson SM; Mitchell ES; Neumaier JF
Biol Psychiatry; 2008 Jan; 63(2):207-13. PubMed ID: 17631868
[TBL] [Abstract][Full Text] [Related]
14. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice.
Mereu M; Tronci V; Chun LE; Thomas AM; Green JL; Katz JL; Tanda G
Addict Biol; 2015 Jan; 20(1):91-103. PubMed ID: 23910902
[TBL] [Abstract][Full Text] [Related]
15. Disruption of a dopamine receptor complex amplifies the actions of cocaine.
Perreault ML; Hasbi A; Shen MYF; Fan T; Navarro G; Fletcher PJ; Franco R; Lanciego JL; George SR
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1366-1377. PubMed ID: 27480020
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
[TBL] [Abstract][Full Text] [Related]
17. Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.
Vazquez-DeRose J; Stauber G; Khroyan TV; Xie XS; Zaveri NT; Toll L
Eur J Pharmacol; 2013 Jan; 699(1-3):200-6. PubMed ID: 23219985
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptor β in the Nucleus Accumbens Regulates the Rewarding Properties of Cocaine in Female Mice.
Satta R; Certa B; He D; Lasek AW
Int J Neuropsychopharmacol; 2018 Apr; 21(4):382-392. PubMed ID: 29294029
[TBL] [Abstract][Full Text] [Related]
19. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
[TBL] [Abstract][Full Text] [Related]
20. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids.
Porter-Stransky KA; Petko AK; Karne SL; Liles LC; Urs NM; Caron MG; Paladini CA; Weinshenker D
Addict Biol; 2020 Nov; 25(6):e12823. PubMed ID: 31441201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
